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Ethnic groupsa b s t r a c t
The COVID-19 pandemic has highlighted existing health inequalities for ethnic minority groups and those
living in more socioeconomically deprived areas in the UK. With higher levels of severe outcomes in these
groups, equitable vaccination coverage should be prioritised. The aim of this study was to identify
inequalities in coverage of COVID-19 vaccination in Wales, UK and to highlight areas which may benefit
from routine enhanced surveillance and targeted interventions.
Records within the Wales Immunisation System (WIS) population register were linked to the Welsh
Demographic Service Dataset (WDSD) and central list of shielding patients, held within the Secure
Anonymised Information Linkage (SAIL) Databank. Ethnic group was derived from the 2011 census and
over 20 administrative electronic health record (EHR) data sources. Uptake of first dose of any COVID-
19 vaccine was analysed over time, with the odds of being vaccinated as at 25th April 2021 by sex, health
board of residence, rural/urban classification, deprivation quintile and ethnic group presented. Using
logistic regression models, analyses were adjusted for age group, care home resident status, health and
social care worker status and shielding status.
This study included 1,256,412 individuals aged 50 years and over. Vaccine coverage increased steadily
from 8th December 2020 until mid-April 2021. Overall uptake of first dose of COVID-19 vaccine in this
group was 92.1%. After adjustment the odds of being vaccinated were lower for individuals who were
male, resident in the most deprived areas, resident in an urban area and an ethnic group other than
White. The largest inequality was seen between ethnic groups, with the odds of being vaccinated 0.22
(95 %CI 0.21–0.24) if in any Black ethnic group compared to any White ethnic group.
Ongoing monitoring of inequity in uptake of vaccinations is required, with better targeted interven-
tions and engagement with deprived and ethnic communities to improve vaccination uptake.
 2021 The Authors. Published by Elsevier Ltd. This is anopenaccess article under the CCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
As at 14th May 2021 the COVID-19 pandemic has led to
3,339,002 deaths worldwide with a total of 160,813,869 confirmed
cases and an unmeasurable impact on peoples wellbeing [1]. A
number of licenced vaccines are providing hope for all that the
pandemic may to come to an end and livelihoods can return to asense of normality. The World Health Organization (WHO) Europe
Health 2020 policy framework highlighted reducing health
inequity both between and within countries, including equitable
access to vaccinations, as a priority [2]. Equitable access to vaccina-
tion is of particular importance given more severe outcomes from
COVID-19 disease has been seen in Black and Asian ethnic groups
and individuals resident in more deprived areas [3–5].
Wales is a nation of the UK with a population of approximately
3.1 million and devolved responsibility for the National Health Ser-
vice (NHS), which provides free health care to the population. As at
6th May 2021 there had been a total of 211,827 confirmed COVID-
19 cases and 5,552 related deaths in Wales [6]. The COVID-19 vac-
cination programme in Wales started on 8th December 2020, and
followed the Joint Committee on Vaccination and Immunisation
(JCVI) guidance on groups to prioritise [7]. Those at highest risk
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this included older adults in care homes, front-line health and
social care staff, adults aged 80 years and older, and those with
clinical risks. Vaccinations were then rolled-out to the adult gen-
eral population in decreasing age order. NHS services in Wales,
including access to vaccinations, are provided by seven health
boards, which cover different geographical regions. Each health
board led its own roll-out of the COVID-19 mass vaccination pro-
gramme, with central provision of vaccines and oversight from a
multi-organisation COVID-19 Vaccination Board (CVB) chaired by
Welsh Government. A national, patient-level vaccination register,
the all Wales Immunisation System (WIS), was developed by Dig-
ital Health Care Wales (DHCW) working alongside delivery and
surveillance stakeholders. The WIS vaccination register was built
on experiences and infrastructure of the pre-existing national child
health data system. WIS primary functions include: scheduling
vaccination clinics, providing patient invitations by written letter
and SMS text, recall of patients to missed appointments, and pro-
viding a national repository of timely vaccination data. The denom-
inator spine of WIS was the national list of those registered for NHS
care in Wales (the Welsh Demographics Service dataset). Within
WIS there is the ability to manually add those not previously reg-
istered for NHS care. To identify those who were a priority for vac-
cination due to clinical or occupational risks, WIS denominator
data were supplemented with additional information from general
practices, the national shielded patient list and health and social
care employers. Invitation letters generated using WIS were posted
to individuals with the date and time of their appointment at a
local mass-vaccination centre, general practice or community
pharmacy, individuals were encouraged to contact a telephone
helpline to rearrange their appointment if they could not attend.
Appointments for the second dose were scheduled at the nation-
ally recommended interval after administration of the first dose.
Pfizer-BioNTech BNT162b2 vaccine was the first to be offered.
Due to the logistics of handling the refrigeration requirements
for this vaccine, the main method of delivery for the early part of
the programme was via mass vaccination clinics, with many
front-line health and social care workers amongst the first to be
vaccinated. Vaccination coverage in care home residents and older
adults increased rapidly throughout January as the Oxford-
AstraZeneca ChAdOx1 vaccine became available, which due to bet-
ter stability at 2–8 C was more suited to smaller vaccination clin-
ics in a wider number of settings. Moderna mRNA-1273 COVID-19
vaccine was supplied for use in Wales from 7th April 2021 in one
health board. As at 15th April 2021 a first dose had been offered
to all individuals aged 50 years and older.
The Public Health Wales (PHW) Vaccine Preventable Disease
Programme (VPDP) provide daily updates on vaccination uptake
through the PHW rapid COVID-19 surveillance dashboard [6]. This
includes a monthly report, showing breakdown of uptake by sex,
social deprivation quintile and ethnic group, with data suggesting
inequity in vaccine uptake exists within the country. However, the
interaction between these factors has not been explored. There are
a number of published studies looking at factors associated with
low vaccination uptake in both children and adults [8–12]. How-
ever, large studies covering whole populations are limited [13–
15]. The majority of studies in adults focus on influenza vaccina-
tion, with low uptake associated with socioeconomic status, eth-
nicity, sex, urban/rural residence, income, educational status,
household size, living alone, co-morbidities, alcohol consumption
and smoking status [9–12].
Reasons for not being vaccinated can be numerous and com-
plex, related to access barriers and challenges in attending
appointments, awareness of reliable information and health liter-
acy, vaccine hesitancy or anti-vaccine views [16]. Prior to the
COVID-19 vaccine roll out, hesitancy had been identified as a6257potential challenge amongst Black and Pakistani ethnic groups,
and also in those with lower levels of education attainment in
the UK [17]. In the US, acceptance was lower in females, younger
adults, Black/African Americans and those without a college degree
[18]. It is important to recognise that equitable access acknowl-
edges that some population groups will need special consideration,
such as tailored method of invitation and access to suitable vacci-
nation venues.
The aim of this study was to look at the equality of coverage of
COVID-19 vaccination in Wales over the first five months of the
mass vaccination programme, and to highlight inequalities which
may benefit from routine enhanced surveillance and targeted
interventions.2. Methods
All analyses were completed via the Secure Anonymised Infor-
mation Linkage (SAIL) Databank, hosted by Swansea University,
as part of the Con-COV project [19]. All individuals aged 50 years
and over as at 31st March 2021 alive, resident and registered for
NHS care in Wales as at 25th April 2021 were included.
Uptake of first dose of (any) COVID-19 vaccine type was anal-
ysed and is presented by sex, health board of residence, rural/ur-
ban classification, deprivation quintile and ethnic group.
Additional characteristics including: age group, care home resident
status, health and social care worker status and shielding status
were added as covariates to allow adjustment for differing charac-
teristics of those prioritised in the vaccine roll out. Odds of being
vaccinated with at least one dose of COVID-19 vaccine as at 25th
April 2021 was estimated using univariable and multivariable
logistic regression.
Sex and Lower-layer Super Output Area (LSOA) of residence was
obtained from the Welsh Demographic Service Dataset (WDSD)
(which is based on individuals registered for NHS care in Wales)
and includes address history, date of birth and date of death. Date
of vaccination, health board of residence, care home resident status
and health and social care worker status were taken from the
Wales Immunisation System (WIS) data, as at 25th April 2021.
WIS contains information on vaccination status, vaccination dates,
vaccination priority/risk group information and limited demo-
graphic information based on all WDSD registered individuals.
The use of WIS, the national person-level vaccine registry, ensures
that analyses are representative of the population of Wales. There
will be small numbers of Welsh residents who are not registered
with the NHS, including unregistered recent migrants, those whose
residency status changes frequently, and those experiencing home-
lessness. However, outreach services are actively offering vaccina-
tion services to groups where possible, including manually
registering unregistered individual with WIS and the wider NHS.
LSOA of residence for an individual’s most recent address was
linked to the Welsh Index of Multiple Deprivation (WIMD) 2019
estimated deprivation scores [20]. Deprivation scores at ecological
(LSOA) level were then ranked and divided in to quintiles to cate-
gorise the most (group 1) and least deprived (group 5) LSOA areas.
Urban/Rural location of residence was assigned by joining LSOA to
the 2011 census rural/urban classification data provided by the
Office for National Statistics (ONS) [21]. Shielding status, was
sourced from the national list of individuals for whom additional
social restrictions were recommended at the start of the COVID-
19 pandemic due to high clinical risk, based on clinician assess-
ment and general practice records, a copy of which is held in SAIL
(CVSP). A standardised set of ethnicity groups were used based on
harmonised ethnicity data from 20 electronic health record (EHR)
data sources across primary and secondary care, as well as admin-
istrative and specialist services data sources available in the SAIL
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gories [22].
Analysis were carried out using R version 4.0.4.
3. Results
The study population included 1,256,412 individuals aged
50 years and over. Overall uptake of the first dose of COVID-19 vac-
cine was 92.1% as at 25th April 2021. Coverage in this age group
increased steadily across age deciles until around the 10th April
when it began to plateau [Fig. 1]. As at 25th April 2021 the largest
inequality in coverage was seen by ethnic group, with a gap of 20.2
percentage points between those in any White ethnic group and
those in any Black ethnic group, a gap of 9.1 percentage points
between those in any White ethnic group and those in any Asian
ethnic group, and gap of 11.6 percentage points between those in
any White ethnic group and those with a Mixed ethnic background
(Table 1). Significant differences were seen across all characteris-
tics, with gaps of 4.3, 4.3, 2.7 and 0.6 percentage points when com-
paring the most and least deprived quintile, health board of
residence with higher and lowest coverage, sex and rural/urban
classification respectively. The gap in coverage observed between
ethnic groups widened over the first five months of the programme
as additional priority groups became eligible [Fig. 1]. However, the
sex gap has narrowed compared to 12.2 percentage points as at 5th
February 2021.
After adjusting for age group, health and social care worker
status, care home resident status and shielding status the odds of
being vaccinated were lower if from a Black (0.22 95 %CIFig. 1. Cumulative uptake of one dose of COVID-19 vaccine (any type) by ethnic group, se
21 a,b. a Data sourced from the all Wales Immunisation System (WIS) in SAIL within the C
deprived areas of Wales small area geography Lower-layer Super Output Area (LSOA) of r
populations divided in to quintiles.
62580.21–0.24), Asian (0.41 95 %CI 0.39–0.43), Mixed ethnic back-
ground (0.36 95 %CI 0.34–0.38) or Other (0.24 95 %CI 0.22–0.27)
ethnic group compared to the aggregated White ethnic group
and also, if resident in the most deprived quintile compared to
the least deprived quintile (0.59 95% CI 0.57–0.60). (Table 1). The
odds of being vaccinated also varied by health board of residence.
The odds of being vaccinated were lower if resident in an urban
area compared to a rural area (0.86 95% CI 0.84–0.87).
4. Discussion
Coverage of the first dose in the population aged 50 years and
older is high and suggests that at a population level, new vaccina-
tions against COVID-19 have been positively received. However, as
with other vaccinations focused at older adults, a number of signif-
icant social inequities in coverage are evident. Despite adjusting for
age, care home resident status, occupation and shielding status,
adults (over 50 years) in Wales are, so far, less likely to be vacci-
nated if they live in a more deprived area or belong to an ethnic
group other than White. Given the media attention, levels of dis-
ease and mortality in older adult age-groups, and the disruption
the COVID-19 pandemic has caused to livelihoods, the overall high
uptake in the population may be unsurprising. This study shows
that, on the whole, for all aged 50 years and over, gaps in coverage
do not appear to be reducing with time, with a risk of increasing
the disproportionate impact of the pandemic on these populations
during future waves [23]. Many administrative health datasets
have large amounts of missing data on ethnicity, with coding com-
pleteness in primary care records <50% in England [22,24]. To ourx, urban/rural residence classification and social quintile of deprivationWales 2020–
OVID Vaccination Data (CVVD) as at 25th April 2021. b To define the most and least
esidence were ranked by Welsh Index of Multiple Deprivation (WIMD) score and the
Table 1
Uptake of one dose of COVID-19 vaccine (any type) and odds of being vaccinated, Wales; April 25, 2021.a,b,c
Univariable Multivariable
Characteristic Category Population (n) Uptake (%) OR 95% CI P-value AOR 95% CI P-value
Ethnicity White 1,134,610 94.1
Black 3,954 73.9 0.18 (0.17–0.19) <0.01 0.22 (0.21–0.24) <0.01
Asian 14,001 85.0 0.36 (0.34–0.37) <0.01 0.41 (0.39–0.43) <0.01
Mixed 7,657 82.5 0.30 (0.28–0.32) <0.01 0.36 (0.34–0.38) <0.01
Other 2,815 75.6 0.20 (0.18–0.21) <0.01 0.24 (0.22–0.27) <0.01
Unknown 93,348 72.0 0.16 (0.16–0.17) <0.01 0.20 (0.19–0.20) <0.01
Health Board HB 1 236,013 93.1
HB 2 291,589 91.1 0.75 (0.74–0.77) <0.01 0.66 (0.65–0.68) <0.01
HB 3 170,399 91.0 0.75 (0.73–0.77) <0.01 0.81 (0.79–0.83) <0.01
HB 4 176,381 93.5 1.06 (1.04–1.09) <0.01 1.03 (1.01–1.06) 0.01
HB 5 167,622 92.7 0.93 (0.91–0.96) <0.01 0.80 (0.78–0.82) <0.01
HB 6 59,962 89.3 0.61 (0.59–0.63) <0.01 0.52 (0.50–0.54) <0.01
HB 7 154,419 92.7 0.94 (0.92–0.96) <0.01 0.86 (0.84–0.88) <0.01
Sex Male 605,751 90.8
Female 650,632 93.4 1.45 (1.43–1.47) <0.01 1.18 (1.16–1.19) <0.01
Location Rural 434,525 92.5
Classification Urban 821,860 91.9 0.92 (0.90–0.93) <0.01 0.86 (0.84–0.87) <0.01
Deprivation Least deprived 276,237 94.0
Quintile 4 273,049 92.5 0.78 (0.76–0.80) <0.01 0.81 (0.79–0.83) <0.01
3 257,936 92.1 0.74 (0.72–0.75) <0.01 0.78 (0.76–0.79) <0.01
2 239,753 91.8 0.72 (0.70–0.73) <0.01 0.71 (0.70–0.73) <0.01
Most deprived 209,410 89.7 0.55 (0.54–0.56) <0.01 0.59 (0.57–0.60) <0.01
a Data sourced from the all Wales Immunisation System (WIS) as at 25th April 2021.
b Multivariate regression model estimates adjusted for ethnic group, health board, sex, urban/rural classification, deprivation quintile of residence, age group, health and
social care worker status, care home resident status, shielding status.
c To assign deprivation quintile, small area geography Lower-layer Super Output Area (LSOA) of residence were ranked by Welsh Index of Multiple Deprivation (WIMD)
score and the populations divided in to quintiles.
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at vaccine coverage, enabling a population-scale analysis of
inequalities.
It cannot be assumed that these results are generalizable to
other nations but they highlight the importance of ensuring
surveillance is in place to make sure no one is left behind in terms
of access to health care and being able to make accurately
informed decisions. Limitations of this study mainly relate to mis-
classification of data. Information may be entered incorrectly in to
WIS and appearing on the shielding list relies on the accurate
recording of clinical risk factors in general practice records. Data
completeness was generally good, although small numbers of indi-
viduals did not have sex information available (<5) and, although it
was possible to attain ethnic group information for the majority of
the study population it was unknown for 7.4% of individuals. Vac-
cination uptake in the population with unknown ethnic group is
low and this is a group that need further investigation. Sociodemo-
graphic data in this study are at ecological level rather than indi-
vidual level, while this demonstrates inequality according to the
overall status of a small area of residence (mean population size
of 1,500), it may be prone to ecological fallacy at individual level.
Ethnic grouping used in this study is broad and further work is
needed to look into minority groups where coverage could be com-
paratively low but it is not apparent when looking at the data
aggregated in this way.
Existing interventions to minimise inequalities include active
invitation by letter, phone or text for all those on the WIS database,
and engagement with underserved communities. Due to the step-
wise roll-out of the vaccination programme to incremental risk
groups, it will be important to track the gap in coverage for specific
age and risk groups, which may show a differed pattern of widen-
ing or narrowing inequality over time.
This study identifies inequality in coverage and further targeted
work is required to ascertain whether the root-causes may be
inequities in service provision or other factors. Geographical clus-
tering of risk groups are potential hotspots for virus transmission
and can be identified in linked databases and prioritised in6259targeted intervention. It is important not to assume that inequali-
ties in coverage are due to differing levels of vaccine hesitancy and
further analysis of opt out/ decliner information would help deter-
mine whether this is the case in Wales, as has been shown else-
where [17,18,25,26].
Additional factors such as access to vaccination clinics for the
elderly who live alone need to be explored [11]. The use of a pop-
ulation register alongside data linkage enables representative anal-
ysis of vaccination inequalities in the population who have
registered for health care. Consideration also needs to be taken
to identify minority groups such as asylum seekers, refugees, the
homeless and travelling population who may face barriers in
accessing health care or registering with services which would
ensure they are invited for vaccination [27–29]. This study has
identified significant inequality in coverage of vaccination, which
is the first step in tailoring services to address underlying causative
factors. Further work is needed to identify the barriers to vaccina-
tion which may be related to accessibility, awareness or accept-
ability. Specific needs of groups who are currently poorly served
by vaccination services will need to be considered. The impact of
publicity and awareness of rare adverse events following vaccina-
tion and perceived safety concerns on uptake of vaccination should
also be taken in to consideration.
Developing robust surveillance systems, utilising data linkage
resources, reducing these inequities and understanding underlying
reasons will benefit the future rollout of COVID-19 vaccination
booster programmes and control of other vaccine preventable dis-
eases such as influenza and pneumococcal disease.
5. Conclusions
This analysis highlights the need for ongoing monitoring of
inequity in uptake of vaccinations. In addition to existing interven-
tions to mitigate inequalities, further engagement should be
undertaken with those in ethnic minority groups and in more
socially deprived areas, including the development of tailored vac-
cination approaches as appropriate to minimise observed inequi-
M. Perry, A. Akbari, S. Cottrell et al. Vaccine 39 (2021) 6256–6261ties in vaccination coverage to prevent severe outcomes from
COVID-19, utilising available resources [30]. Closing the vaccina-
tion equity gap before further waves of infection occur should be
a priority.
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